男嫌いなスレンダー美乳の連れ子に媚薬を飲ませて一週間。子宮が疼き、理性を失った娘は、嫌がりながらも俺の巨根を求めるようになった。 Box Office Collection, Budget & Verdict

Detailed Financial Report

The financial journey of 男嫌いなスレンダー美乳の連れ子に媚薬を飲ませて一週間。子宮が疼き、理性を失った娘は、嫌がりながらも俺の巨根を求めるようになった。 began with its theatrical debut in 2025. Production insiders estimate the budget to be around an undisclosed amount. This figure typically includes principal photography, talent fees, and post-production costs, but often excludes marketing and distribution expenses which can add another 30-50% to the total investment.

Collection Trajectory

The box office journey for 男嫌いなスレンダー美乳の連れ子に媚薬を飲ませて一週間。子宮が疼き、理性を失った娘は、嫌がりながらも俺の巨根を求めるようになった。 has culminated in a worldwide gross of approximately TBA. The momentum at the ticket windows suggested a niche appeal rather than a broad mass-market breakout.

Profitability & Verdict

In the modern film economy, theatrical revenue is just one slice of the pie. However, it remains the primary indicator of a film's "Hit" or "Flop" status. Based on the reported numbers and audience reception (0/10), 男嫌いなスレンダー美乳の連れ子に媚薬を飲ませて一週間。子宮が疼き、理性を失った娘は、嫌がりながらも俺の巨根を求めるようになった。 is effectively categorized as a Financial Disappointment.

Comparables

When compared to other Drama releases of 2025, 男嫌いなスレンダー美乳の連れ子に媚薬を飲ませて一週間。子宮が疼き、理性を失った娘は、嫌がりながらも俺の巨根を求めるようになった。 stands as a testament to the volatile nature of the genre. Its performance will likely influence studio decisions for future projects in this category.